Description
Tecentriq 840mg Injection is a powerful immunotherapy medication used in the treatment of certain types of cancer. Its active ingredient is Atezolizumab, a monoclonal antibody designed to target and block the PD-L1 protein. By inhibiting PD-L1, Tecentriq helps to unleash the body’s own immune system to recognize and attack cancer cells. This medication is indicated for the treatment of specific forms of non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), urothelial carcinoma, and melanoma, often in combination with other cancer therapies or as a standalone treatment depending on the cancer type and stage. The typical dosage and administration schedule are determined by a healthcare professional based on the patient’s specific condition and response to treatment. Common side effects can include fatigue, nausea, diarrhea, rash, and infusion-related reactions. Serious side effects, though less common, may involve immune-related adverse events affecting various organs. Tecentriq 840mg Injection should be stored at room temperature, protected from light, and should not be frozen. Always follow your doctor’s instructions regarding its use and handling.
